Work for Cue Biopharma, Inc.?

Claim Your Profile

Cue Biopharma, Inc. Logo Image

Cue Biopharma, Inc.

Cue Biopharma, Inc. Banner Image

About Cue Biopharma, Inc.

11-50 Employees
Based in Cambridge, Massachusetts

Cue Biopharma, a clinical-stage biopharmaceutical company, is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells within the body to transform the treatment of cancer, infectious diseases and autoimmune diseases. The company’s proprietary platform, Immuno-STAT™ (Selective Targeting and Alteration of T cells) is designed to harness the body’s intrinsic immune system without the need for ex vivo manipulation.

Ticker:
CUE
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol